The former found that ANXA2 binds to these peptides and mediates their effects [77], while the latter showed that ANXA2 facilitates the uptake of progastrin into cells via the clathrin-mediated endocytic pathway, resulting in activation of MAP Kinases that promote tumor cell growth and survival. The gene discussed is ANXA2; the disease is neoplasm.